Edison, NJ 的 多發性骨髓瘤 臨床試驗
22 項針對 多發性骨髓瘤 的研究正在 Edison（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
招募中2 期
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 距離 15 英里
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
招募中3 期
- Astera Cancer Care, East Brunswick · 距離 6 英里
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
招募中3 期
- Astera Cancer Care, East Brunswick · 距離 6 英里
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
招募中3 期
- MSK Basking Ridge, Basking Ridge · 距離 15 英里
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
招募中4 期
- Rutgers Cancer Institute of New Jersey, New Brunswick · 距離 3 英里
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
招募中2 期
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 距離 15 英里
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
招募中2 期
- Rutgers Cancer Institute of New Jersey, New Brunswick · 距離 3 英里
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
招募中3 期
- MSK Basking Ridge, Basking Ridge · 距離 15 英里
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
招募中1 期
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 距離 15 英里
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
招募中3 期
- Research Site, East Brunswick · 距離 6 英里
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
招募中觀察性研究
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 距離 15 英里
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
招募中1/2 期
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 距離 15 英里
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
招募中2 期
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 距離 15 英里
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
招募中2 期
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 距離 15 英里
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
招募中早期第 1 期
- Rutgers Cancer Institute of New Jersey, New Brunswick · 距離 3 英里
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Brunswick · 距離 3 英里
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
招募中1/2 期
- Rutgers Cancer Institute of New Jersey, New Brunswick · 距離 3 英里
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
招募中1 期
- Rutgers Cancer Institute of New Jersey /ID# 266833, New Brunswick · 距離 3 英里
A Dietary Study for People With Multiple Myeloma
招募中
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 距離 15 英里
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
招募中1/2 期
- Rutgers Cancer Institute of New Jersey, New Brunswick · 距離 3 英里
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
招募中2 期
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 距離 15 英里
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
招募中觀察性研究歡迎健康志工
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 距離 15 英里
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
招募中
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 距離 15 英里
其他城市的 多發性骨髓瘤 試驗
- New York City, NY60 項研究
- Boston, MA42 項研究
- Atlanta, GA41 項研究
- Houston, TX38 項研究
- Durham, NC37 項研究
- Nashville, TN32 項研究
- Denver, CO27 項研究
- Rochester, MN24 項研究
- St. Louis, MO24 項研究
- Columbus, OH24 項研究
- Baldwin Park, CA23 項研究
- Chicago, IL22 項研究
Edison 的其他研究
- 乳癌68 項研究
- 非小細胞肺癌47 項研究
- 癌症（所有類型）33 項研究
- 前列腺癌29 項研究
- 大腸直腸癌23 項研究
- 肺癌23 項研究
- 膀胱癌21 項研究
- 轉移性癌症20 項研究
- 卵巢癌20 項研究
- 急性髓系白血病20 項研究
- 子宮內膜癌19 項研究
- 尿路上皮（移行細胞）癌18 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。